首页> 外文OA文献 >Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

【2h】

Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

机译：阿扎胞苷和供体淋巴细胞输注同种异体干细胞移植治疗急性髓性白血病或骨髓增生异常综合症复发-德国合作移植研究小组的回顾性多中心分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Schroeder Thomas; Rachlis Elena; Bug Gesine; Stelljes Matthias; Klein Stefan; Steckel Nina Kristin; Wolf Dominik; Ringhoffer Mark; Czibere Akos; Nachtkamp Kathrin; Dienst Ariane; Kondakci Mustafa; Stadler Michael; Platzbecker Uwe; Uharek Lutz; Luft Thomas; Fenk Roland; Germing Ulrich; Bornhäuser Martin; Kröger Nicolaus; Beelen Dietrich W.; Haas Rainer; Kobbe Guido;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Donor Lymphocyte Infusion for the Treatment of Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation [J] . Takami Akiyoshi, Yano Shingo, Yokoyama Hiroki, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2014,第11期

机译：供体淋巴细胞输注治疗异基因造血干细胞移植后复发的急性髓样白血病：日本造血细胞移植协会成人急性髓样白血病工作组的回顾性分析
2. Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome [J] . Guillaume Thierry, Malard Florent, Magro Leonardo, Bone marrow transplantation . 2019,第11期

机译：预防性低剂量氮杂硝乙汀和供体淋巴细胞输注的前瞻性期II研究在同种异体造血干细胞移植治疗高危急性髓性白血病和骨髓增生术综合征
3. Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome [J] . Guillaume Thierry, Yakoub-Agha Ibrahim, Tabrizi Reza, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：高风险急性髓细胞白血病和骨髓增生异常综合征同种异体造血干细胞移植后预防性阿扎胞苷和供体淋巴细胞输注的前瞻性II期研究
4. Computationally derived cytological image markers for predicting risk of relapse in acute myeloid leukemia patients following bone marrow transplantation [C] . Sara ArabYarmohammadi, Zelin Zhang, Patrick Leo, Conference on Medical Imaging: Digital Pathology . 2020

机译：计算源自骨髓移植后急性髓性白血病患者复发风险的细胞学图像标志物
5. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
6. Phase I Study of Azacitidine following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation [O] . Armin Ghobadi, Jaebok Choi, Mark A. Fiala, -1

机译：供体淋巴细胞输注后阿扎胞苷用于异基因干细胞移植后复发的急性髓细胞性白血病的I期研究
7. Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548) [O] . Schroeder T., Czibere A.G., Kröger N., 2011

机译：将阿扎胞苷（Vidaza®，Aza）和供体淋巴细胞输注（DLI）结合作为异基因造血干细胞移植（allo-SCT）复发的急性髓样白血病（AML）或骨髓增生异常综合征（MDS）复发的患者（PTS）的首次抢救治疗： Azarela试用版的中期分析（NCT-00795548）

Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

著录项

相似文献

相关主题

期刊订阅